A Randomized Double-blind Placebo-controlled Multicenter Study to Evaluate the Safety Tolerability and Efficacy of XEN1101 as Adjunctive Therapy in Focal-onset Epilepsy
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
